Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This study will determine what effect taking a combination of five anti-HIV drugs during the
early stage of HIV infection, then temporarily stopping them once or twice, may have on the
amount of HIV virus in the blood (viral load). The study will also evaluate the safety and
effectiveness of this anti-HIV drug combination.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)